Centurion+ Patent Holders as of October 8, 2024

Simon F Williams

CEO at Akeso Biomedical.

A visionary entrepreneur with 30 years of experience in creating, organizing, developing, licensing, financing and managing new medical, chemical, and animal healthcare technologies from early stage research through to commercially viable products.

Extensive experience with absorbable medical devices, biodegradable polymers, and feed additives for animals, and devising and implementing product development strategies to leverage new polymer and chemical technologies. 

Patent №: 12109100 (October 8, 2024) – Three-dimensional resorbable implants for tissue reinforcement and hernia repair. Resorbable three-dimensional implants have been developed for minimally invasive procedures, designed to temporarily deform for easy implantation and resume their original shape in the body. Made from poly-4-hydroxybutyrate mesh with reinforced borders, these implants are ideal for tissue reinforcement and hernia repair, particularly in areas like the inguinofemoral region. Once in place, they conform smoothly to the host’s tissue without wrinkling or folding.

Serge Saxonov

Chief Executive Officer, Co-founder

Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception.

Before 10x Genomics, Serge was Vice President of Applications at QuantaLife, building products and defining the company’s growth areas. Serge was the first employee at 23andMe, where he served as Founding Architect and Director of R&D.

There Serge defined the initial concept of the product, built out the core technology, and drove strategy and execution of R&D functions. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.

Patent №: 12110549 (October 8, 2024) – Methods and systems for processing polynucleotides. This disclosure presents compositions, methods, systems, and devices for polynucleotide processing and analyte characterization, such as through sequencing. It includes barcoded oligonucleotides bound to beads for tagging and analyzing proteins, DNA, and RNA.

Akash Kumar

RF FW Development and 3GPP Standardization in 5G NR at Qualcomm.

Patent №: 12114233 (October 8, 2024) – User location aware smart event handling.

Techniques for sending notifications to users are discussed. An example method includes receiving a notification from an alerting device, identifying the recipient, determining their location and preferences, selecting a suitable notification device based on these factors, and sending the alert message, which includes the recipient’s preferences and details of the alerting device.

Chi-Chun Liu

Research Staff Member at IBM.

Dr. Liu has been a staff member at IBM Research since June 2012. Previously he was a researcher at IBM Research, Almaden Research Laboratory (February 2011 – June 2012), a research assistant at the University of Wisconsin-Madison (September 2005 – September 2010), and an etch process engineer at the Taiwan Semiconductor Manufacturing Company (April 2002 – August 2005).

He is the co-inventor of the “LiNe” (Liu-Nealey) flow. It is one of the industry’s first and most widely used DSA processes.

Patent №: 12113013 (October 8, 2024) – Dual color via patterning. The device includes: a first dielectric material with a first metal line; a second dielectric material placed on top of the first dielectric material and metal line; a second metal line within the second dielectric material; and multiple metal vias on the same level connecting the first and second metal lines. These metal vias have different sidewall profile angles for the top and bottom vias.